Nike, Inc. vs XPeng Inc. — Stock Comparison
Q·Score Breakdown
6.6
Neutral
Overall
7.3
Bullish
Quality
Health
Growth
Valuation
Sentiment
NKE
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 35% year-over-year.
XPEV
Consistently beats earnings estimates (4/4 quarters).
⚠ currently unprofitable (-1% margin).
Analyst Consensus
HOLD
Target $61.68 (+38.9%)
33 analysts
BUY
Target $24.67 (+55.9%)
26 analysts
Fundamentals
NKE
XPEV
29.2×
Trailing P/E
—
24.1×
Forward P/E
23.0×
4.8%
Profit Margin
-1.5%
40.9%
Gross Margin
19.0%
16.0%
ROE
-3.7%
0.1%
Revenue Growth
38.2%
-34.8%
Earnings Growth
—
1.32
Beta
1.18
—
Price / Book
—
$65.8B
Market Cap
$15.1B
$42 – $80
52-Week Range
$15 – $28
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →